Hospital – acquired pneumonia (HAP) and ventilator – associated pneumonia (VAP) represent a significant healthcare burden with increased mortality among critically ill patients. Unfortunately, universal definitions and established clinical characteristics remain debated, especially in patients receiving extracorporeal membrane oxygenation (ECMO) support for cardiopulmonary failure. This study evaluates factors associated with respiratory culture positivity in patients receiving ECMO.
Methods
In this single – center retrospective cohort of adult patients receiving ECMO between January 2022 and June 2024; we evaluated clinical parameters and patient factors associated with suspected HAP/VAP, defined as a new positive respiratory culture with clinical characteristics of infection. Additionally, isolated organisms were assessed for persistent positivity.
Results
Among the 88 samples collected from 35 patients, no clinical or laboratory differences were identified when comparing samples with positive organisms recovered vs negative culture growth. ECMO-associated HAP/VAP incidence rate was 18.7 per 1000 ECMO – days. Recovered pathogens were primarily from the Enterobacteriaceae family or Pseudomonas aeruginosa at 33.3% and 27.8% respectively. Only 27.3% of patients who met criteria for HAP/VAP had evidence of radiographic changes. A minority of HAP/VAPs (27.3%) had microbiologic cure after treatment completion and no patient cleared Burkholderia cepacia, Staphylococcus aureus, or Stenotrophomonas maltophilia in this cohort.
Conclusion
Timely diagnosis and management of HAP/VAP is essential in the care of the critically ill. However, clear incidence rates and diagnostic accuracy has been hindered by heterogenous definitions and poor sensitivity/specificity of clinical indicators. The need for a unified diagnostic criteria are amplified in ECMO where clinical management is confounded by a persistent proinflammatory state and frequent respiratory tract colonization.
CombesAPeekGJHajageD, et al.ECMO for severe ARDS: systematic review and individual patient data meta-analysis. Intensive Care Med2020; 46(11): 2048–2057. https://doi.org/10.1007/s00134-020-06248-3
2.
RajsicSTremlBJadzicD, et al.Extracorporeal membrane oxygenation for cardiogenic shock: a meta-analysis of mortality and complications. Ann Intensive Care2022; 12(1): 93. https://doi.org/10.1186/s13613-022-01067-9
3.
PeekGJMugfordMTiruvoipatiR, et al.Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet Lond Engl2009; 374(9698): 1351–1363. https://doi.org/10.1016/S0140-6736(09)61069-2
4.
TonnaJEAbramsDBrodieD, et al.Management of adult patients supported with venovenous extracorporeal membrane oxygenation (VV ECMO): Guideline from the extracorporeal life support organization (ELSO). ASAIO J Am Soc Artif Intern Organs2021; 67(6): 601–610. https://doi.org/10.1097/MAT.0000000000001432
5.
SauerCMYuhDDBondeP. Extracorporeal membrane oxygenation use has increased by 433% in adults in the United States from 2006 to 2011. ASAIO J Am Soc Artif Intern Organs2015; 61(1): 31–36. https://doi.org/10.1097/MAT.0000000000000160
6.
StentzMJKelleyMEJabaleyCS, et al.Trends in extracorporeal membrane oxygenation growth in the United States, 2011-2014. ASAIO J Am Soc Artif Intern Organs2019; 65(7): 712–717. https://doi.org/10.1097/MAT.0000000000000872
7.
MatthayMAArabiYArroligaAC, et al.A new global definition of acute respiratory distress syndrome. Am J Respir Crit Care Med2024; 209(1): 37–47. https://doi.org/10.1164/rccm.202303-0558WS
8.
QadirNSahetyaSMunshiL, et al.An update on management of adult patients with acute respiratory distress syndrome: an official American thoracic society clinical practice guideline. Am J Respir Crit Care Med2024; 209(1): 24–36. https://doi.org/10.1164/rccm.202311-2011ST
9.
IannattonePAYangSSKoolianM, et al.Incidence of venous thromboembolism in adults receiving extracorporeal membrane oxygenation: a systematic review. ASAIO J Am Soc Artif Intern Organs2022; 68(12): 1523–1528. https://doi.org/10.1097/MAT.0000000000001694
10.
SyESklarMCLequierL, et al.Anticoagulation practices and the prevalence of major bleeding, thromboembolic events, and mortality in venoarterial extracorporeal membrane oxygenation: a systematic review and meta-analysis. J Crit Care2017; 39: 87–96. https://doi.org/10.1016/j.jcrc.2017.02.014
11.
BiffiSDi BellaSScaravilliV, et al.Infections during extracorporeal membrane oxygenation: epidemiology, risk factors, pathogenesis and prevention. Int J Antimicrob Agents2017; 50(1): 9–16. https://doi.org/10.1016/j.ijantimicag.2017.02.025
12.
Glater-WeltLBSchneiderJBZingerMM, et al.Nosocomial bloodstream infections in patients receiving extracorporeal life support: variability in prevention practices: a survey of the extracorporeal life support organization members. J Intensive Care Med2016; 31(10): 654–669. https://doi.org/10.1177/0885066615571540
13.
BurketJSBartlettRHVander HydeK, et al.Nosocomial infections in adult patients undergoing extracorporeal membrane oxygenation. Clin Infect Dis Off Publ Infect Dis Soc Am1999; 28(4): 828–833. https://doi.org/10.1086/515200
14.
AitHAVahedian-AzimiAIbrahimAS, et al.Incidence, risk factors and outcomes of nosocomial infection in adult patients supported by extracorporeal membrane oxygenation: a systematic review and meta-analysis. Crit Care Lond Engl2024; 28(1): 158.
15.
GrasselliGScaravilliVDiBS, et al.Nosocomial infections during extracorporeal membrane oxygenation: incidence, etiology, and impact on patients’ outcome. Crit Care Med2017; 45(10): 1726–1733. https://doi.org/10.1097/CCM.0000000000002652
16.
WangLNiKWangY, et al.Nosocomial infections in adult patients receiving extracorporeal membrane oxygenation in China: a retrospective cohort study. Am J Infect Control2023; 51(11): 1237–1241. https://doi.org/10.1016/j.ajic.2023.04.010
17.
LiZJZhangDFZhangWH. Analysis of nosocomial infection and risk factors in patients with ECMO treatment. Infect Drug Resist2021; 14: 2403–2410. https://doi.org/10.2147/IDR.S306209
18.
HsuMSChiuKMHuangYT, et al.Risk factors for nosocomial infection during extracorporeal membrane oxygenation. J Hosp Infect2009; 73(3): 210–216. https://doi.org/10.1016/j.jhin.2009.07.016
19.
FrerouALesouhaitierMGregoireM, et al.Venoarterial extracorporeal membrane oxygenation induces early immune alterations. Crit Care Lond Engl2021; 25(1): 9. https://doi.org/10.1186/s13054-020-03444-x
20.
SweetLMMarcusJE. A systematic review of variability in the reporting of extracorporeal membrane oxygenation-associated infections and recommendations for standardization. Am J Infect Control2024; 52(10): 1209–1214. https://doi.org/10.1016/j.ajic.2024.05.005
21.
BizzarroMJConradSAKaufmanDA, et al.Extracorporeal life support organization task force on infections, extracorporeal membrane oxygenation. Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc2011; 12(3): 277–281. https://doi.org/10.1097/PCC.0b013e3181e28894
22.
American Thoracic Society, Infectious Diseases Society of AmericaInfectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med2005; 171(4): 388–416. https://doi.org/10.1164/rccm.200405-644ST
23.
KalilACMeterskyMLKlompasM, et al.Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society. Clin Infect Dis Off Publ Infect Dis Soc Am2016; 63(5): e61–e111. https://doi.org/10.1093/cid/ciw353
MelsenWGRoversMMGroenwoldRHH, et al.Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis2013; 13(8): 665–671. https://doi.org/10.1016/S1473-3099(13)70081-1
26.
LuytCESahnounTGautierM, et al.Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study. Ann Intensive Care2020; 10(1): 158. https://doi.org/10.1186/s13613-020-00775-4
27.
FranchineauGLuytCECombesA, et al.Ventilator-associated pneumonia in extracorporeal membrane oxygenation-assisted patients. Ann Transl Med2018; 6(21): 427. https://doi.org/10.21037/atm.2018.10.18
28.
TanCHotaSSFanE, et al.Bloodstream infection and ventilator-associated pneumonia in patients with coronavirus disease 2019 (COVID-19) supported by extracorporeal membrane oxygenation. Infect Control Hosp Epidemiol2023; 44(9): 1443–1450. https://doi.org/10.1017/ice.2022.290
29.
MassartNCamusCNesselerN, et al.Multiple-site decontamination to prevent acquired infection in patients with veno-venous ECMO support. Ann Intensive Care2023; 13(1): 27. https://doi.org/10.1186/s13613-023-01120-1
30.
MarcusJEShahAPeekGJ, et al.Nosocomial infections in adults receiving extracorporeal membrane oxygenation: a review for infectious diseases clinicians. Clin Infect Dis Off Publ Infect Dis Soc Am2024; 79(2): 412–419. https://doi.org/10.1093/cid/ciae120
31.
JacksonLBSobieszczykMJAdenJK, et al.Fever and leukocytosis are poor predictors of bacterial coinfection in patients with COVID-19 and influenza who are receiving extracorporeal membrane oxygenation. Open Forum Infect Dis2023; 10(11): ofad501. https://doi.org/10.1093/ofid/ofad501
32.
PatelKDAdenJKSobieszczykMJ, et al.The utility of procalcitonin for identifying secondary infections in patients with influenza or COVID-19 receiving extracorporeal membrane oxygenation. Ther Adv Infect Dis2024; 11: 20499361241255873. https://doi.org/10.1177/20499361241255873
33.
EnglandJLeeRMarshallT, et al.Analysis of diagnostic criteria for ECMO-Associated pneumonia. Infect Control Hosp Epidemiol2024; 46(1): 1–3. https://doi.org/10.1017/ice.2024.181
34.
RanzaniOTSenussiTIdoneF, et al.Invasive and non-invasive diagnostic approaches for microbiological diagnosis of hospital-acquired pneumonia. Crit Care Lond Engl2019; 23(1): 51. https://doi.org/10.1186/s13054-019-2348-2
